Impacts of clinicopathological factors on efficacy of trastuzumab deruxtecan in patients with HER2-positive metastatic breast cancer
2022 · The Breast · 21 citations
https://doi.org/10.1016/j.breast.2022.01.002
S
Shota Kusuhara
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
190
Citations
8
h-index
7
i10-index
Shota Kusuhara is an academic researcher from National Cancer Center Hospital East. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & HER2/EGFR in Cancer Research & Advanced Breast Cancer Therapies. The author has an h-index of 8, co-authored 18 publications.
Papers by this author
worksThe efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis
2021 · The Breast · 8 citations
https://doi.org/10.1016/j.breast.2021.04.001
Safety and pharmacokinetics of imaradenant (AZD4635) in Japanese patients with advanced solid malignancies: a phase I, open-label study
2023 · Cancer Chemotherapy and Pharmacology · 3 citations
https://doi.org/10.1007/s00280-023-04605-9
The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancer
2025 · Cancer Treatment and Research Communications · 1 citations
https://doi.org/10.1016/j.ctarc.2025.100941
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat